Abstract
Background: Number of people dying from IHD has increased from 0.61 million in 1990 to 1.13 million in 2010, which is a disturbing fact. According to a report by the World Health Organization, India would be spending a whopping 237 billion US dollars, owing to direct spending on health care and indirectly due to loss of productivity due to IHD. Ischemia Reversal Program (IRP) is a combination of Panchakarma and allied therapy. This study was conducted to evaluate the effect of IRP on VO₂max, Duke’s treadmill score, systolic blood pressure (SBP), diastolic blood pressure (DBP), and dependency on conventional therapy in IHD patients.
Methods: This observational study was conducted in January 2017, wherein the data of IHD patients (inducible ischemia on stress testing) who attended out-patient departments (OPDs) at Madhavbaug clinics in Maharashtra, India, were identified. Data of patients who were administered IRP (60–75 minutes) with a minimum of 7 sittings over 90 days (±15 days) were considered. Variables were compared between day 1 and day 90 of the IRP.
Results: Out of 38 enrolled patients, 25 were males while 13 were females. There was significant improvement in Duke’s score, with subjects at moderate (50%) and high (31.6%) risk at baseline being significantly decreased to low (52.6%) and moderate (47.4%) after the 90th day of therapy. IRP also showed significant improvement in VO₂max by 9.11 (from 20.29 ± 6.72 to 29.40 ± 6.71; p < 0.001), SBP by 5.78 (from 128.78 ± 17.40 to 123 ± 12.23; p < 0.03), and DBP by 4.76 (from 80.53 ± 8.10 to 75.76 ± 6.85; p < 0.005). Dependency on concomitant medicines was reduced.
Conclusions: IRP was effective in IHD; it had dual benefits, i.e., anti-ischemic effect, as well as reducing the dependency on allopathic medicines.
Locate a Centre
